Study results indicate that discovery of recently evolved protein could lead to new targets for neuropsychiatric disorders and novel treatments for patients AstraZeneca and the Lieber Institute for Brain Development (LIBD), an affiliate of the Johns Hopkins University School of ...
Read More »